Herein following is a post that was deleted on the KMA-

New Post Public Reply Private Reply Replies (0) Message Board
Jaime Rodriquez
Herein following is a post that was deleted on the KMA- forum by the administrator, presumably shelly, and on the pretext of being ''off topic''. Actually, I don't know what could have been more ''on topic'' than this post, but no matter. ''she'' & the lie-hub powers like her, are in the drivers seat, as regards which posts remain, and which post get deleted, the which as we all know, is decidedly in the side of the bashers & (more) negative posters, those who hardly ever have anything good to say about either company. So, at any rate, good luck in SRGE & GOOD LUCK IN kma-, whoever you may be.










jaimerodriques
Monday, January 14, 2013 11:44:40 AM


With regards to another stock that I .......

......that I happen to be involved in, here is a little something that I replied to one of the big name players who was pronouncing the death knell for that stock, too, just like so many have and are still trying to do here. So, in talking about that stock, since I was really talking about this stock, ie: KMAG, I just thought that that post from over there might be a blessing for all of the enthusiastic KMAG investors over here! And then hope that my one post for the day (YEP! It happened again!) might make it! Now follows that other post from that other forum, you all know which one it is!

Hi, Te---: you said in your post #120751:

''Tickers that go grey and do not go back to pinks die in time, just another fact.''

But what if they (eventually) DO get reinstated, if not ''back to the OTC.PK'', then up to the OTC.BB, 

BY DOING EVERYTHING THAT THEY HAVE TO DO, AS AT LEAST ONE COMPANY THAT I KNOW OF IS DOING! NAMELY KMAG!

What happens then, ey? Do they still, ''just die'', even if their 3rd quarter for 2012 shows that they are up almost 1600% over the same time period from the year before? Or if the company has no debt? Or if the CEO personally has bought back & holds 240 million shares out of an A/S of 750 million shares, thus making the float only circa 550 million shares, and most of those (now) being held by longs who are strong about the stock & company & CEO? And what if SR-- shows via their quarterlies that they are still making tremendous income, and that their legal team is making progress toward getting a new TA & a new MM, as also of having their quarterlies and/or annuals AUDITED, ey? And also succeeds in getting the 211 properly approved? So, what happens then, to SR--, if the CEO M------ D----- & his management team do all of that & more, ey? Does SR-- still, just finally die a slow death via trading in the greys~kingdom? Even if the mining company is still making money every quarter & lots of it?

What happens then, ey? GO SR--! VIVA SR--! INNOCENT UNTIL PROVEN GUILTY & until ''the fat lady has sung'', is supposed to be the ''AMERICAN WAY'', is it not?

For tomorrow is just one day, perhaps even a very trying day, in the ''WHOLE LIFE'' of this company! For if this mining company really is a survivor, like some other CEO & some other company that I know (KMAG), THEN IT WILL SURVIVE! And it will survive quite contrary to all that the nay-sayers may try to say about it, too! For time only shall tell the ''end'' of this particular tale, for it is just too blessed early to pronounce its death knell! IMO



Southridge Enterprises Inc. (SRGE) Stock Research Links

SRGE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 8

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 2

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Shell plc Announces Re-Appointment of EY Following Audit Tender

Updated Category News Views 541

Shell plc Moves Forward with External Auditor Appointment Shell plc is excited to share the outcomes of its recent audit tender process, a necessary step in ensuring robust governance and accountability within the company. After a comprehensive evaluation led by the Audit and Risk Committee, the Board has given its seal of approval for the re-appointment of Ernst & Young...

Continue Reading
Con Edison to Host Webcast for Investor Insights on Energy

Updated Category News Views 241

Consolidated Edison Hosts Investor Webcast on Energy Solutions Consolidated Edison, Inc. (NYSE: ED) is excited to announce an upcoming webcast titled Delivering Reliable and Resilient Energy for the Future, designed to engage with investors and stakeholders about the company's strategic direction and initiatives. This live presentation is scheduled for the morning of...

Continue Reading
Navigating Market Trends: Insights from BTIG on S&P 500

Updated Category News Views 63

Market Outlook from BTIG: A Bumpy Road Ahead The S&P 500 index has encountered several challenges lately. However, investment bank BTIG believes the future looks bright, with expectations of a positive trend despite some bumps in the road. Current Market Analysis Initially, there were hopes for a breakout for the S&P 500 after the recent interest rate cuts by the Federal...

Continue Reading
John Hancock Preferred Income II's Shares Surge to New Highs

Updated Category News Views 132

John Hancock Preferred Income II Reaches New Milestone In an impressive display of resilience, John Hancock Preferred Income II (HPF) stock has reached a remarkable 52-week high, currently trading at $18.88 USD. This new peak is significant, reflecting a substantial 36.5% change in the stock's price over the year. The sharp increase in value indicates heightened investor...

Continue Reading
Ultimate Medical Academy Shines with National Workplace Awards

Updated Category News Views 86

Ultimate Medical Academy Celebrates Recognition for Workplace Excellence Ultimate Medical Academy (UMA) has recently garnered significant accolades, marking an achievement in cultivating a nurturing workplace culture. The institution has once again showcased its commitment by securing a position on the 2024 Top Workplaces list, accompanied by three distinguished awards...

Continue Reading